Skip to main content

Table 1 Clinicopathologic characteristics of the four cohorts

From: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

CharacteristicHCC (n = 9)CCa (n = 4)GBC (n = 3)PCa (n = 1)p value
Age at surgery, years58 [49–62]67 [60–72]49 [38–66]64 [64]0.438
Gender (male/female)8 (89)/1 (11)1 (25)/3 (75)2 (67)/1 (33)1 (100)/0 (0)0.082
ASA score III/IV9 (100)3 (75)3 (100)1 (100)0.559
Prior abdominal surgery6 (67)3 (75)3 (100)0 (0)0.626
Synchronous/metachronous PC1 (11)/8 (89)2 (50)/2 (50)0 (0)/3 (100)1 (100)/0 (0)0.082
Neoadjuvant chemotherapy1 (11)2 (50)3 (100)1 (100)0.012*
  1. HCC hepatocellular carcinoma, CCa cholangiocarcinoma, GBC gallbladder cancer, PCa pancreatic cancer, PC peritoneal carcinomatosis
  2. * p<0.05